Abstract
A survey of all member societies of the European Association of Nuclear Medicine has shown that a satisfactory degree of harmonisation exists for the quality assurance of the preparation and handling of radio-pharmaceuticals and the performance of nuclear medicine instrumentation. However, variations were found in acquisition protocols, data analysis and the interpretation and presentation of clinical results. Harmonisation of these areas of a nuclear medicine investigation would help ensure the overall quality. A European initiative is proposed to collect and collate procedures in these areas in order to produce a reference framework of good practice for the acquisition, analysis and interpretation of nuclear medicine investigations. This would involve collaboration between national societies and exchange of information with and support from European organisations, taking into account relevant international activities. The reference framework should be compatible with quality management guidelines.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
ISO 9000.Quality management and quality assurance standard: guidelines for selection and use. ANSUASQC Q90.
ISO 9001.Quality systems model for quality assurance in design/development, production, installation and servicing. ANSI/ASQC Q91.
ISO 9002.Quality systems — model for quality assurance in production and installation. ANSUASQC Q92.
EEC Directive of 3rd September 1984.Official Journal of the European Communities, L265, vol 27, 84/466 Euratom, 5th October 1984, ISSN 0378-6978.
European Standard EN 28402. 1991Quality vocabulary.
Characteristics and test conditions for Anger-type gamma cameras. Geneva: International Electrotechnical Commission, 1992.
Quality control of nuclear medicine instruments. IAEA-TECDOC 602. Vienna: International Atomic Energy Agency, 1991.
US Pharmacopoeia XXII. United States Pharmacopoeial Convention, Rockville, Md., 1990.
European Pharmacopoeia, 2nd edn, part 2, monograph 124. Maisonneuve, Sainte-Ruffine: Council of Europe, 1982: 1–4.
Frier M, Hardy JG, Hesselwood SR, Lawrence R.Hospital radiopharmacy — principles and practice. IPSM Report No. 56. York: Institute of Physical Sciences in Medicine, 1988.
Cosgriff PS, Lawson RS, Nimmon CC. Towards standardization in gamma camera renography.Nucl Med Commun 1992; 13:580–585.
Bergmann H, Mostbeck A, Kletter K, Nicoletti R, Oberladstätter M. Empfehlungen zur Durchführung von nuklearmedizinsichen Nierenfunktionsuntersuchungen mit Gamma Kamera und Computer.Acta Med Austr 1991; 18 Suppl 43: 1–19.
Bourguignon MH, Busemann-Sokole E, Jones B, van der Wall E. Protocols for the selection of cardiac radionuclide studies for use as a data base of normal studies and typical patterns of diseases.Eur J Nucl Med 1993; 20: 59–65.
Verhoeff NPLG, Büll U, Costa DC, Kirsch G, Lottes G, Moretti JL, Podreka I, Schober O, van Royen EA. Basics and recommendations for brain SPECT.Nucl Med 1993; 31: 114–131.
Oie HY, Blokland JAK, eds. Nederlandse Vereniging voor Nucleaire Geneeskunde, Commissie Kwaliteitsbevordering “Aanbevelingen Nucleair Geneeskundige Diagnostiek”. Eburon Delft, 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bergmann, H., Busemann-Sokole, E. & Horton, P.W. Quality assurance and harmonisation of nuclear medicine investigations in Europe. Eur J Nucl Med 22, 477–480 (1995). https://doi.org/10.1007/BF00839063
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00839063